Sloan M H, Bissonnette B, Lerman J
Department of Anaesthesia, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Anaesthesia. 1998 Jan;53(1):36-40. doi: 10.1111/j.1365-2044.1998.00259.x.
The combination of vecuronium and atracurium was studied in 60 children of ASA physical status 1 or 2. In part I, the dose-response relationships were determined in 30 children who were randomly assigned to receive a single bolus of 0.02, 0.025 or 0.03 mg kg-1 of vecuronium or 0.075, 0.01 or 0.0125 mg.kg-1 of atracurium. The evoked electromyogram of the adductor pollicis brevis muscle to train-of-four stimulation was monitored. The speed of onset of the neuromuscular blockade was determined by a 95% depression of the train-of-four whereas the recovery index was established at 75% recovery of T1. In part II, 30 children were randomly assigned to receive 2 x ED95 of vecuronium, 2 x ED95 of atracurium, or a combination of 1 x ED95 of vecuronium + 1 x ED95 of atracurium. This study showed that the ED50 and ED95 for vecuronium were 0.021 mg.kg-1 and 0.037 mg.kg-1 and for atracurium 0.11 mg.kg-1 and 0.30 mg.kg-1, respectively. The slopes of the dose-response relationships were significantly different (p < 0.001). With vecuronium alone, the speed of onset of neuromuscular blockade was significantly slower (p < 0.001) and the duration of action less (p < 0.001) than that with atracurium alone or with the combination. There were no differences between atracurium and the combination of both medications. The recovery index was similar for all groups. We conclude that the dose-response relationships of vecuronium and atracurium in children undergoing halothane anaesthesia are not parallel and the neuromuscular effects of vecuronium and atracurium are neither additive nor synergistic. While vecuronium has a shorter duration of action than atracurium, this feature is not apparent when it is combined with atracurium in equipotent doses. Recovery is rapid and not prolonged when these two drugs are combined.
对60例美国麻醉医师协会(ASA)身体状况为1或2级的儿童进行了维库溴铵和阿曲库铵联合用药的研究。在第一部分中,对30名儿童进行了研究,他们被随机分配接受单次静脉注射0.02、0.025或0.03mg/kg的维库溴铵,或0.075、0.1或0.125mg/kg的阿曲库铵。监测拇短收肌对四个成串刺激的诱发肌电图。神经肌肉阻滞的起效速度通过四个成串刺激幅度降低95%来确定,而恢复指数则在T1恢复75%时确定。在第二部分中,30名儿童被随机分配接受2倍维库溴铵有效剂量95%(ED95)、2倍阿曲库铵ED95或1倍维库溴铵ED95 + 1倍阿曲库铵ED95的联合用药。该研究表明,维库溴铵的ED50和ED95分别为0.021mg/kg和0.037mg/kg,阿曲库铵的ED50和ED95分别为0.11mg/kg和0.30mg/kg。剂量-反应关系的斜率有显著差异(p < 0.001)。单独使用维库溴铵时,神经肌肉阻滞的起效速度明显较慢(p < 0.001),作用持续时间较短(p < 0.001),与单独使用阿曲库铵或联合用药相比。阿曲库铵与两种药物联合使用之间没有差异。所有组的恢复指数相似。我们得出结论,在接受氟烷麻醉的儿童中,维库溴铵和阿曲库铵的剂量-反应关系不平行,维库溴铵和阿曲库铵的神经肌肉效应既非相加也非协同。虽然维库溴铵的作用持续时间比阿曲库铵短,但当它与等效能剂量的阿曲库铵联合使用时,这一特征并不明显。当这两种药物联合使用时,恢复迅速且不延长。